Skip to main content

ARK Genomic Revolution ETF

ARK · Tracks (actively managed — no index) · Inception Oct 31, 2014

Expense ratio
0.75%
75.0 bps
Net assets
$2.22B
TTM yield
0.00%
Last price
$48.16
as of Oct 23, 2026
Avg volume
5,581,973
shares/day, 30d

Trailing returns

through Oct 23, 2026
1 year
+53.8%
3 year
+27.6%
annualized
5 year
-8.5%
annualized
Growth of $1, 2021-11 to 2026-10

Price return from month-end closes, distributions reinvested at month end. Excludes trading costs, bid-ask spreads and taxes. Past performance says nothing about future returns and is not part of the composite score — see the methodology for what the score does measure.

Composite score

48 / 100
Cost 25

Based on a 0.75% expense ratio.

Liquidity 72

Based on $2.22B in net assets.

Concentration 30

Top-10 holdings represent 59.1% of net assets.

Tax efficiency 78

Thematic base · ETF wrapper · 0.00% TTM yield.

The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.2).

Look through ARKG, or compare the fee

Top holdings

33 total holdings · as of Jul 31, 2026
# Holding Weight
1 10X GENOMICS INC 9.39%
2 TWIST BIOSCIENCE CORP 7.73%
3 TEMPUS AI INC 6.56%
4 CRISPR THERAPEUTICS AG 6.29%
5 PERSONALIS INC 5.47%
6 ABSCI CORP 5.14%
7 GUARDANT HEALTH INC 4.74%
8 ILLUMINA INC 4.74%
9 ELI LILLY & COMPANY 4.68%
10 CAREDX INC 4.30%

Compare ARKG with another fund

Or skim the closest-overlap funds below.

Similar ETFs by holdings overlap

Open ARKG at a brokerage

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings sourced from SEC Form N-PORT-P (accession 0000940400-26-037946).